Objective: To assess consultant practices and attitudes concerning the use of intravesical BCG for CIS, and high grade superficial TCC bladder in England and Wales. Materials and methods: Consultants in England and Wales, identified from the BAUS members handbook were sent a questionnaire survey to determine their usage of BCG and the reasons why they adopted their chosen practice. Results: Three hundred and sixteen completed questionnaires were returned, giving a response rate for the questionnaire of 70%. Although, the vast majority adopted a regimen of a weekly instillation of BCG for 6 weeks for an initial treatment course, the practice of maintenance therapy varied nationally. In addition to this, initial follow up of BCG patients, and how to manage the BCG "failures" also differed amongst consultant urologists in England and Wales. Conclusions: In patients receiving BCG, a consensus view should be sought to determine optimal management.
|Number of pages||4|
|Publication status||Published - Jun 2002|
- Bacille Calmette-Guerin
- Consultant urologists
- Transitional cell carcinoma